Your team is focused on developing novel immunotherapies for autoimmune diseases. What can you tell us about the research to date? My laboratory was for many years focused on understanding the immunology of malaria. It was through that research that we discovered that a molecule known as programmed cell death 1 ligand 2 (PD-L2) controlled ...
A/Prof Michelle Wykes: How understanding of PD-L2 in malaria is helping research into autoimmune disease
31 May 2021